{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T04:57:48Z","timestamp":1794891468677,"version":"4.9.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T00:00:00Z","timestamp":1714348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T00:00:00Z","timestamp":1714348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-024-02792-z","type":"journal-article","created":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T21:01:18Z","timestamp":1714424478000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Silk Fibroin Formed Bioadhesive Ophthalmic Gel for Dry Eye Syndrome Treatment"],"prefix":"10.1208","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-2557-8007","authenticated-orcid":false,"given":"Tianjiao","family":"Hao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianzi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zengjing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bohui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jirong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,29]]},"reference":[{"issue":"5","key":"2792_CR1","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1001\/jama.2021.19963","volume":"327","author":"FE Hakim","year":"2022","unstructured":"Hakim FE, Farooq AV. Dry eye disease: an update in 2022. Jama. 2022;327(5):478\u20139.","journal-title":"Jama"},{"issue":"10","key":"2792_CR2","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1007\/s10792-022-02320-7","volume":"42","author":"R Huang","year":"2022","unstructured":"Huang R, Su C, Fang L, et al. Dry eye syndrome: comprehensive etiologies and recent clinical trials. International ophthalmology. 2022;42(10):3253\u201372.","journal-title":"International ophthalmology"},{"key":"2792_CR3","doi-asserted-by":"publisher","unstructured":"Zemanov\u00e1 M. Dry eye disease. A review. Ceska a slovenska oftalmologie: casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti. 2021;77(3):107\u201319. https:\/\/doi.org\/10.31348\/2023\/27.","DOI":"10.31348\/2023\/27"},{"issue":"2","key":"2792_CR4","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1097\/IIO.0000000000000170","volume":"57","author":"CS de Paiva","year":"2017","unstructured":"de Paiva CS. Effects of Aging in Dry Eye. Int Ophthalmol Clin. 2017;57(2):47\u201364.","journal-title":"Int Ophthalmol Clin"},{"issue":"11","key":"2792_CR5","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.amjmed.2011.01.030","volume":"124","author":"W Yao","year":"2011","unstructured":"Yao W, Davidson RS, Durairaj VD, et al. Dry eye syndrome: an update in office management. Am J Med. 2011;124(11):1016\u20138.","journal-title":"Am J Med"},{"key":"2792_CR6","doi-asserted-by":"publisher","first-page":"8281","DOI":"10.2147\/IJN.S173691","volume":"13","author":"Y Shen","year":"2018","unstructured":"Shen Y, Yu Y, Chaurasiya B, et al. Stability, safety, and transcorneal mechanistic studies of ophthalmic lyophilized cyclosporine-loaded polymeric micelles. Int J Nanomed. 2018;13:8281\u201396.","journal-title":"Int J Nanomed"},{"issue":"6","key":"2792_CR7","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1093\/bjd\/ljac016","volume":"188","author":"AM Trier","year":"2023","unstructured":"Trier AM, Kim BS. Insights into atopic dermatitis pathogenesis lead to newly approved systemic therapies. Br J Dermatol. 2023;188(6):698\u2013708.","journal-title":"Br J Dermatol"},{"issue":"5","key":"2792_CR8","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1111\/all.15608","volume":"78","author":"V Schmidt","year":"2023","unstructured":"Schmidt V, Lalev\u00e9e S, Traidl S, et al. Intravenous immunoglobulins, cyclosporine, and best supportive care in epidermal necrolysis: diverse effects on systemic inflammation. Allergy. 2023;78(5):1280\u201391.","journal-title":"Allergy"},{"key":"2792_CR9","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.bcp.2019.03.022","volume":"163","author":"AM Liddicoat","year":"2019","unstructured":"Liddicoat AM, Lavelle EC. Modulation of innate immunity by cyclosporine A. Biochem Pharmacol. 2019;163:472\u201380.","journal-title":"Biochem Pharmacol"},{"key":"2792_CR10","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/164_2019_331","volume":"261","author":"B T\u00f6NSHOFF","year":"2020","unstructured":"T\u00f6NSHOFF B. Immunosuppressants in organ transplantation. Handbook Exp Pharmacol. 2020;261:441\u201369.","journal-title":"Handbook Exp Pharmacol"},{"issue":"4","key":"2792_CR11","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1080\/14728214.2021.2011858","volume":"26","author":"L Mason","year":"2021","unstructured":"Mason L, Jafri S, Dortonne I, et al. Emerging therapies for dry eye disease. Expert Opin Emerg Drugs. 2021;26(4):401\u201313.","journal-title":"Expert Opin Emerg Drugs"},{"issue":"8","key":"2792_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0271267","volume":"17","author":"L Qian","year":"2022","unstructured":"Qian L, Wei W. Identified risk factors for dry eye syndrome: a systematic review and meta-analysis. PloS one. 2022;17(8): e0271267.","journal-title":"PloS one"},{"issue":"3","key":"2792_CR13","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1097\/ICU.0000000000000569","volume":"30","author":"EC O'Neil","year":"2019","unstructured":"O\u2019Neil EC, Henderson M, Massaro-Giordano M, et al. Advances in dry eye disease treatment. Curr Opin Ophthalmol. 2019;30(3):166\u201378.","journal-title":"Curr Opin Ophthalmol"},{"issue":"3","key":"2792_CR14","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1089\/jop.2019.0060","volume":"36","author":"LM Periman","year":"2020","unstructured":"Periman LM, Perez VL, Saban DR, et al. The immunological basis of dry eye disease and current topical treatment options. J Ocular Pharmacol Ther Off J Assoc Ocular Pharmacol Ther. 2020;36(3):137\u201346.","journal-title":"J Ocular Pharmacol Ther Off J Assoc Ocular Pharmacol Ther"},{"issue":"44","key":"2792_CR15","doi-asserted-by":"publisher","first-page":"6988","DOI":"10.1039\/D0PY00919A","volume":"11","author":"DD Nguyen","year":"2020","unstructured":"Nguyen DD, Lai J-Y. Advancing the stimuli response of polymer-based drug delivery systems for ocular disease treatment. Poly Chem. 2020;11(44):6988\u20137008.","journal-title":"Poly Chem"},{"issue":"2\u20133","key":"2792_CR16","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0162-3109(00)00192-2","volume":"47","author":"S Matsuda","year":"2000","unstructured":"Matsuda S, Koyasu S. Mechanisms of action of cyclosporine. Immunopharmacology. 2000;47(2\u20133):119\u201325.","journal-title":"Immunopharmacology"},{"issue":"7\u20138","key":"2792_CR17","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1080\/09273948.2020.1757121","volume":"29","author":"L Tong","year":"2021","unstructured":"Tong L, Sun CC, Yoon KC, et al. Cyclosporine anionic and cationic ophthalmic emulsions in dry eye disease: a literature review. Ocular Immunol Inflam. 2021;29(7\u20138):1606\u201315.","journal-title":"Ocular Immunol Inflam"},{"issue":"5","key":"2792_CR18","first-page":"639","volume":"97","author":"I Zghal","year":"2019","unstructured":"Zghal I, Fekih O, Zgolli HM, et al. Cyclosporin A eye drop and subepithelial adenoviral keratoconjunctivitis infiltrates. La Tunisie Med. 2019;97(5):639\u201343.","journal-title":"La Tunisie Med"},{"issue":"20","key":"2792_CR19","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.2174\/0929867327666201006153202","volume":"28","author":"J Patocka","year":"2021","unstructured":"Patocka J, Nepovimova E, Kuca K, et al. Cyclosporine A: chemistry and toxicity - a review. Curr Med Chem. 2021;28(20):3925\u201334.","journal-title":"Curr Med Chem"},{"issue":"6","key":"2792_CR20","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1007\/s13346-019-00650-1","volume":"9","author":"D Patel","year":"2019","unstructured":"Patel D, Wairkar S. Recent advances in cyclosporine drug delivery: challenges and opportunities. Drug Del Trans Res. 2019;9(6):1067\u201381.","journal-title":"Drug Del Trans Res"},{"key":"2792_CR21","doi-asserted-by":"publisher","first-page":"4187","DOI":"10.2147\/OPTH.S279051","volume":"14","author":"LM Periman","year":"2020","unstructured":"Periman LM, Mah FS, Karpecki PM. A review of the mechanism of action of cyclosporine A: The role of cyclosporine A in dry eye disease and recent formulation developments. Clin Ophthalmol (Auckland, NZ). 2020;14:4187\u2013200.","journal-title":"Clin Ophthalmol (Auckland, NZ)"},{"key":"2792_CR22","first-page":"95","volume":"121","author":"E Wolska","year":"2018","unstructured":"Wolska E, Sznitowska M, Chor\u0105\u017cewicz J, et al. Ocular irritation and cyclosporine A distribution in the eye tissues after administration of solid lipid microparticles in the rabbit model. Eur J Pharm Sci Off J Eur Federation Pharm Sci. 2018;121:95\u2013105.","journal-title":"Eur J Pharm Sci Off J Eur Federation Pharm Sci"},{"issue":"5","key":"2792_CR23","doi-asserted-by":"publisher","first-page":"295","DOI":"10.5935\/0004-2749.20150078","volume":"78","author":"LR Parrilha","year":"2015","unstructured":"Parrilha LR, Nai GA, Giuffrida R, et al. Comparison of 1% cyclosporine eye drops in olive oil and in linseed oil to treat experimentally-induced keratoconjunctivitis sicca in rabbits. Arquivos Brasileiros De Oftalmologia. 2015;78(5):295\u20139.","journal-title":"Arquivos Brasileiros De Oftalmologia"},{"issue":"3","key":"2792_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1167\/tvst.4.3.1","volume":"4","author":"K Cholkar","year":"2015","unstructured":"Cholkar K, Gilger BC, Mitra AK. Topical, aqueous, clear cyclosporine formulation design for anterior and posterior ocular delivery. Trans Vis Sci Technol. 2015;4(3):1.","journal-title":"Trans Vis Sci Technol"},{"issue":"2","key":"2792_CR25","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.clae.2009.10.005","volume":"33","author":"C Ma\u00efssa","year":"2010","unstructured":"Ma\u00efssa C, Guillon M, Simmons P, et al. Effect of castor oil emulsion eyedrops on tear film composition and stability. Contact Lens Anter Eye J Br Contact Lens Assoc. 2010;33(2):76\u201382.","journal-title":"Contact Lens Anter Eye J Br Contact Lens Assoc"},{"key":"2792_CR26","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ejpb.2017.03.006","volume":"117","author":"F Lallemand","year":"2017","unstructured":"Lallemand F, Schmitt M, Bourges JL, et al. Cyclosporine A delivery to the eye: a comprehensive review of academic and industrial efforts. Eur J Pharm Biopharm Off J Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik eV. 2017;117:14\u201328.","journal-title":"Eur J Pharm Biopharm Off J Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik eV"},{"issue":"12","key":"2792_CR27","doi-asserted-by":"publisher","first-page":"4290","DOI":"10.1021\/acs.molpharmaceut.1c00370","volume":"18","author":"R Yan","year":"2021","unstructured":"Yan R, Xu L, Wang Q, et al. Cyclosporine A nanosuspensions for ophthalmic delivery: a comparative study between cationic nanoparticles and drug-core mucus penetrating nanoparticles. Mol Pharm. 2021;18(12):4290\u20138.","journal-title":"Mol Pharm"},{"issue":"3 Pt B","key":"2792_CR28","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.ejpb.2013.08.003","volume":"85","author":"H Yu","year":"2013","unstructured":"Yu H, Xia D, Zhu Q, et al. Supersaturated polymeric micelles for oral cyclosporine A delivery. Eur J Pharm Biopharm Off J Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik eV. 2013;85(3 Pt B):1325\u201336.","journal-title":"Eur J Pharm Biopharm Off J Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik eV"},{"issue":"3","key":"2792_CR29","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1081\/DDC-52058","volume":"31","author":"JD Quintana-Hau","year":"2005","unstructured":"Quintana-Hau JD, Cruz-Olmos E, L\u00f3PEZ-S\u00e1NCHEZ MI, et al. Characterization of the novel ophthalmic drug carrier Sophisen in two of its derivatives: 3A Ofteno and Modusik-A Ofteno. Drug Devel Ind Pharm. 2005;31(3):263\u20139.","journal-title":"Drug Devel Ind Pharm"},{"issue":"3","key":"2792_CR30","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1007\/s10384-022-00906-3","volume":"66","author":"JW Rhim","year":"2022","unstructured":"Rhim JW, Eom Y, Yoon EG, et al. Efficacy of a 0.05% cyclosporine a topical nanoemulsion in dry eyes with obstructive meibomian gland dysfunction. Japan J Ophthalmol. 2022;66(3):254\u201363.","journal-title":"Japan J Ophthalmol"},{"key":"2792_CR31","doi-asserted-by":"publisher","first-page":"122535","DOI":"10.1016\/j.ijpharm.2022.122535","volume":"631","author":"GS Gomes","year":"2023","unstructured":"Gomes GS, Frank LA, Contri RV, et al. Nanotechnology-based alternatives for the topical delivery of immunosuppressive agents in psoriasis. Int J Pharm. 2023;631:122535.","journal-title":"Int J Pharm"},{"issue":"12","key":"2792_CR32","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.18240\/ijo.2022.12.05","volume":"15","author":"YJ Jo","year":"2022","unstructured":"Jo YJ, Lee JE, Lee JS. Clinical efficacy of 0.05% cyclosporine nano-emulsion in the treatment of dry eye syndrome associated with meibomian gland dysfunction. Int J Ophthalmol. 2022;15(12):1924\u201331.","journal-title":"Int J Ophthalmol"},{"issue":"12","key":"2792_CR33","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.3390\/biology10121328","volume":"10","author":"L Huang","year":"2021","unstructured":"Huang L, Liang W, Zhou K, et al. Therapeutic effects of fenofibrate nano-emulsion eye drops on retinal vascular leakage and neovascularization. Biology. 2021;10(12):1328.","journal-title":"Biology"},{"issue":"5","key":"2792_CR34","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1080\/10837450.2018.1550789","volume":"24","author":"MJ Alvarez-Figueroa","year":"2019","unstructured":"Alvarez-Figueroa MJ, Abarca-Riquelme JM, Gonz\u00e1lez-Aramundiz JV. Influence of protamine shell on nanoemulsions as a carrier for cyclosporine-A skin delivery. Pharm Devel Technol. 2019;24(5):630\u20138.","journal-title":"Pharm Devel Technol"},{"key":"2792_CR35","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.nbd.2017.08.012","volume":"108","author":"O Binyamin","year":"2017","unstructured":"Binyamin O, Keller G, Frid K, et al. Continues administration of Nano-PSO significantly increased survival of genetic CJD mice. Neurobiol Dis. 2017;108:140\u20137.","journal-title":"Neurobiol Dis"},{"key":"2792_CR36","doi-asserted-by":"publisher","unstructured":"Patnaik SK, Halder N, Chawla B, et al. Comparison of ocular pharmacokinetics of etoposide and its nanoemulsion after subtenon administration in rabbits. J Basic Clin Physiol Pharmacol. 2019;30(5). https:\/\/doi.org\/10.1515\/jbcpp-2018-0108.","DOI":"10.1515\/jbcpp-2018-0108"},{"key":"2792_CR37","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ejpb.2015.01.018","volume":"91","author":"Y Dong","year":"2015","unstructured":"Dong Y, Dong P, Huang D, et al. Fabrication and characterization of silk fibroin-coated liposomes for ocular drug delivery. Eur J Pharm Biopharm Off J Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik eV. 2015;91:82\u201390.","journal-title":"Eur J Pharm Biopharm Off J Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik eV"},{"issue":"1","key":"2792_CR38","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1080\/17425247.2023.2154075","volume":"20","author":"X Wang","year":"2023","unstructured":"Wang X, Anton H, Vandamme T, et al. Updated insight into the characterization of nano-emulsions. Expert Opinion Drug Del. 2023;20(1):93\u2013114.","journal-title":"Expert Opinion Drug Del"},{"issue":"1","key":"2792_CR39","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1080\/21691401.2018.1561457","volume":"47","author":"AK Jain","year":"2019","unstructured":"Jain AK, Thareja S. In vitro and in vivo characterization of pharmaceutical nanocarriers used for drug delivery. Art Cells Nanomed Biotechnol. 2019;47(1):524\u201339.","journal-title":"Art Cells Nanomed Biotechnol"},{"issue":"19","key":"2792_CR40","doi-asserted-by":"publisher","first-page":"6910","DOI":"10.3390\/molecules28196910","volume":"28","author":"AS Doghish","year":"2023","unstructured":"Doghish AS, Shehabeldine AM, El-Mahdy HA, et al. Thymus vulgaris oil nanoemulsion: synthesis, characterization, antimicrobial and anticancer activities. Molecules. 2023;28(19):6910. https:\/\/doi.org\/10.3390\/molecules28196910.","journal-title":"Molecules."},{"issue":"6","key":"2792_CR41","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.3390\/molecules28062540","volume":"28","author":"MK Sah","year":"2023","unstructured":"Sah MK, Gautam B, Pokhrel KP, et al. Quantification of the Quercetin nanoemulsion technique using various parameters. Molecules (Basel, Switzerland). 2023;28(6):2540.","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"6","key":"2792_CR42","doi-asserted-by":"publisher","first-page":"3180","DOI":"10.1039\/D1RA08184E","volume":"12","author":"X Fu","year":"2022","unstructured":"Fu X, Gao Y, Yan W, et al. Preparation of eugenol nanoemulsions for antibacterial activities. RSC Advances. 2022;12(6):3180\u201390.","journal-title":"RSC Advances"},{"issue":"Suppl 2","key":"2792_CR43","first-page":"S816","volume":"12","author":"O Indrati","year":"2020","unstructured":"Indrati O, Martien R, Rohman A, et al. Development of nanoemulsion-based hydrogel containing andrographolide: physical properties and stability evaluation. J Pharm Bioal Sci. 2020;12(Suppl 2):S816-s20.","journal-title":"J Pharm Bioal Sci"},{"issue":"12","key":"2792_CR44","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.3390\/pharmaceutics14122585","volume":"14","author":"S Senapati","year":"2022","unstructured":"Senapati S, Youssef AAA, Sweeney C, et al. Cannabidiol loaded topical ophthalmic nanoemulsion lowers intraocular pressure in normotensive Dutch-belted rabbits. Pharmaceutics. 2022;14(12):2585.","journal-title":"Pharmaceutics"},{"key":"2792_CR45","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.jconrel.2020.10.025","volume":"328","author":"M Singh","year":"2020","unstructured":"Singh M, Bharadwaj S, Lee KE, et al. Therapeutic nanoemulsions in ophthalmic drug administration: concept in formulations and characterization techniques for ocular drug delivery. J Control Rel Off J Control Rel Soc. 2020;328:895\u2013916.","journal-title":"J Control Rel Off J Control Rel Soc"},{"key":"2792_CR46","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1477-3155-11-27","volume":"11","author":"SH Ng","year":"2013","unstructured":"Ng SH, Woi PM, Basri M, et al. Characterization of structural stability of palm oil esters-based nanocosmeceuticals loaded with tocotrienol. J Nanobiotechnol. 2013;11:27.","journal-title":"J Nanobiotechnol"},{"issue":"6","key":"2792_CR47","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1248\/cpb.c22-00134","volume":"70","author":"S Kimura","year":"2022","unstructured":"Kimura S, Mori S, Yokoya M, et al. Multiple stimuli-responsive supramolecular gel formed from modified adenosine. Chem Pharm Bull. 2022;70(6):443\u20137.","journal-title":"Chem Pharm Bull"},{"key":"2792_CR48","first-page":"9437468","volume":"2022","author":"L Jiang","year":"2022","unstructured":"Jiang L, Sun S, Chen J, et al. Random forest algorithm-based ultrasonic image in the diagnosis of patients with dry eye syndrome and its relationship with tear osmotic pressure. Comput Math Methods Med. 2022;2022:9437468.","journal-title":"Comput Math Methods Med"},{"issue":"5","key":"2792_CR49","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1097\/ICO.0000000000000368","volume":"34","author":"RM Dutescu","year":"2015","unstructured":"Dutescu RM, Panfil C, Schrage N. Osmolarity of prevalent eye drops, side effects, and therapeutic approaches. Cornea. 2015;34(5):560\u20136.","journal-title":"Cornea"},{"issue":"4","key":"2792_CR50","doi-asserted-by":"publisher","first-page":"425","DOI":"10.3390\/polym10040425","volume":"10","author":"M Vicario-De-La-Torre","year":"2018","unstructured":"Vicario-De-La-Torre M, Caballo-Gonz\u00e1lez M, Vico E, et al. Novel nano-liposome formulation for dry eyes with components similar to the preocular tear film. Polymers. 2018;10(4):425.","journal-title":"Polymers"},{"issue":"2","key":"2792_CR51","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1080\/03639045.2016.1238924","volume":"43","author":"GM Hotujac","year":"2017","unstructured":"Hotujac GM, Jureti\u0107 M, Hafner A, et al. Tear fluid-eye drops compatibility assessment using surface tension. Drug Devel Ind Pharm. 2017;43(2):275\u201382.","journal-title":"Drug Devel Ind Pharm"},{"issue":"5","key":"2792_CR52","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.3390\/nu11051052","volume":"11","author":"BH Chen","year":"2019","unstructured":"Chen BH, Stephen IB. Nanoemulsion and nanoliposome based strategies for improving anthocyanin stability and bioavailability. Nutrients. 2019;11(5):1052.","journal-title":"Nutrients"},{"key":"2792_CR53","doi-asserted-by":"publisher","first-page":"102768","DOI":"10.1016\/j.cis.2022.102768","volume":"309","author":"R Mozafarpour","year":"2022","unstructured":"Mozafarpour R, Koocheki A, Sani MA, et al. Ultrasound-modified protein-based colloidal particles: interfacial activity, gelation properties, and encapsulation efficiency. Adv Colloid Interf Sci. 2022;309:102768.","journal-title":"Adv Colloid Interf Sci"},{"issue":"1\u20132","key":"2792_CR54","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.ijpharm.2018.06.025","volume":"547","author":"Y Lv","year":"2018","unstructured":"Lv Y, He H, Qi J, et al. Visual validation of the measurement of entrapment efficiency of drug nanocarriers. Int J Pharm. 2018;547(1\u20132):395\u2013403.","journal-title":"Int J Pharm"},{"key":"2792_CR55","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.jconrel.2020.08.020","volume":"327","author":"Y Dong","year":"2020","unstructured":"Dong Y, Hengst L, Hunt R, et al. Evaluating drug distribution and release in ophthalmic emulsions: impact of release conditions. J Control Rel Off J Control Rel Soc. 2020;327:360\u201370.","journal-title":"J Control Rel Off J Control Rel Soc"},{"issue":"11","key":"2792_CR56","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1136\/bjo.2008.156828","volume":"93","author":"H Mochizuki","year":"2009","unstructured":"Mochizuki H, Yamada M, Hatou S, et al. Turnover rate of tear-film lipid layer determined by fluorophotometry. Br J Ophthalmol. 2009;93(11):1535\u20138.","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"2792_CR57","doi-asserted-by":"publisher","first-page":"246","DOI":"10.2174\/1872211314666191224115211","volume":"13","author":"Z Qamar","year":"2019","unstructured":"Qamar Z, Qizilbash FF, Iqubal MK, et al. Nano-based drug delivery system: recent strategies for the treatment of ocular disease and future perspective. Recent Patents Drug Del Formulation. 2019;13(4):246\u201354.","journal-title":"Recent Patents Drug Del Formulation"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-024-02792-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-024-02792-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-024-02792-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T16:05:38Z","timestamp":1725379538000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-024-02792-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,29]]},"references-count":57,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["2792"],"URL":"https:\/\/doi.org\/10.1208\/s12249-024-02792-z","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,29]]},"assertion":[{"value":"30 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"92"}}